PATIENT MEDICATION
ADHERENCE IN NUMBERS

  • 50% adherence rate for chronic patients
  • 70% of nonadherence is caused by behavioral reasons.
  • 125K deaths every year in the US alone.
  • $250B/yr potential revenue loss to US Pharma.
  • $300B/yr in avoidable costs to the health care system.

THE PROACTIVE HEALTH AGENT

XOLTAR revolutionizes remote patient digital interaction through an engaging live video chat between the patient and an AI agent with a human touch. XOLTAR’s unique technology combines Machine Learning algorithms together with Behavioral Science, helping patients remove barriers throughout the treatment journey.

XOLTAR’s digital representatives can see, hear, use context and even identify non-verbal cues, enabling real-time, goal-driven, natural flowing sessions. Unlike other conversational AI solutions that lack a true understanding of meaning or context, XOLTAR digital representative/assistant/nurse can process any conversational input in real-time, generate insights, and weave them naturally back into the conversation. These qualities facilitate a human-like dialogue, encouraging engagement and behavioral change in patient adherence at scale.

XOLTAR allows payers and pharma to assist millions of patients simultaneously and improve their quality of life.

HOW IT WORKS

FOUNDERS

Asaf Shiloni

CEO & Co-Founder

Tal Meller

CPO & Co-Founder

FOUNDING TEAM

Yizhar Feldman

COO

Zack Hershkovich

VP R&D

Shlomo Neuberger

Full-Stack Developer

Dr. Alon Goldstein

Chief Behavioral Officer

Ran Avigad

CG Architect

Yisrael Hessler

Student

Dr. Ariel Goldstein

NLP Researcher

ADVISORY

Arnon Shafir

BD Advisor

Hanan Miron

Financial Advisor

Matteo Shapira

Experience Advisor

Elya Tagar

Global Health Advisor

Prof. Nate Shapiro

Medical Advisor

Jocelyn Nowak

Healthcare BD Advisor